Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Long-Term Debt Repayments: 2009-2025

Historic Long-Term Debt Repayments for Northwest Biotherapeutics (NWBO) over the last 7 years, with Sep 2025 value amounting to $475,000.

  • Northwest Biotherapeutics' Long-Term Debt Repayments fell 13.79% to $475,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year increase of 124.19%. This contributed to the annual value of $1.1 million for FY2024, which is 188.31% up from last year.
  • Per Northwest Biotherapeutics' latest filing, its Long-Term Debt Repayments stood at $475,000 for Q3 2025, which was down 11.38% from $536,000 recorded in Q1 2025.
  • In the past 5 years, Northwest Biotherapeutics' Long-Term Debt Repayments registered a high of $4.0 million during Q1 2022, and its lowest value of $2,000 during Q3 2023.
  • Over the past 3 years, Northwest Biotherapeutics' median Long-Term Debt Repayments value was $242,500 (recorded in 2023), while the average stood at $282,125.
  • In the last 5 years, Northwest Biotherapeutics' Long-Term Debt Repayments tumbled by 98.00% in 2023 and then soared by 27,450.00% in 2024.
  • Over the past 5 years, Northwest Biotherapeutics' Long-Term Debt Repayments (Quarterly) stood at $3.8 million in 2021, then tumbled by 97.41% to $99,000 in 2022, then spiked by 76.77% to $175,000 in 2023, then soared by 77.14% to $310,000 in 2024, then fell by 13.79% to $475,000 in 2025.
  • Its Long-Term Debt Repayments stands at $475,000 for Q3 2025, versus $536,000 for Q1 2025 and $310,000 for Q4 2024.